Previous Close | 76.51 |
1-Year Change | 8.33% |
6-Months Change | 6.44% |
3-Months Change | 2.66% |
Moving Avg (50d) | 75.112 |
Moving Avg (200d) | 73.207 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 12.1B |
Beta (3-Years) | 1.14 |
Revenue Growth (ttm) | 2.37% |
Net Profit Margin (ttm) | 21.57% |
Return On Assets (ttm) | 8.95% |
EPS (ttm) | 1.51 |
PE Ratio (ttm) | 50.67 |
Dividend Yield | 0.63% |
Asset Description: | Bio-Techne Corporation |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-18 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
74.98 | 72.685 | 71.154 | 68.859 | 65.034 | 61.208 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.